BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 17166107)

  • 41. Hyperinsulinaemia, a key factor of the metabolic syndrome in postmenopausal women.
    Gaspard U
    Maturitas; 2009 Apr; 62(4):362-5. PubMed ID: 19131194
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Hypoglycemic pharmacological treatment of type 2 diabetes: targeting the endothelium.
    Nathanson D; Nyström T
    Mol Cell Endocrinol; 2009 Jan; 297(1-2):112-26. PubMed ID: 19038307
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Obesity and the metabolic syndrome in the elderly--a mini-review.
    Lechleitner M
    Gerontology; 2008; 54(5):253-9. PubMed ID: 18841025
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Management of diabetes in cardiac diseases].
    Işik S; Delibaşi T; Berker D; Aydin Y; Güler S
    Anadolu Kardiyol Derg; 2009 Jun; 9(3):238-47. PubMed ID: 19520659
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Problems of insulin resistance.
    Moller DE; Flier JS
    Hosp Pract (Off Ed); 1988 Oct; 23(10A):83-4, 86, 89 passim. PubMed ID: 3141439
    [No Abstract]   [Full Text] [Related]  

  • 46. Glucose and insulin metabolism in obese youth.
    Burgert TS
    Pediatr Endocrinol Rev; 2006 Dec; 3 Suppl 4():555-9. PubMed ID: 17237742
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Correlation of acanthosis nigricans with insulin resistance, anthropometric, and other metabolic parameters in diabetic Indians.
    Patidar PP; Ramachandra P; Philip R; Saran S; Agarwal P; Gutch M; Gupta KK
    Indian J Endocrinol Metab; 2012 Dec; 16(Suppl 2):S436-7. PubMed ID: 23565457
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Acanthosis nigricans in adolescents: a practical approach.
    De Sanctis V; Soliman A; Marsciani A; Timoncini G; Reggiani L; Zucchini A; Altieri E
    Georgian Med News; 2013 Sep; (222):73-8. PubMed ID: 24099818
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Acanthosis nigricans: a new cutaneous sign in severe atopic dermatitis and Down syndrome.
    Muñoz-Pérez MA; Camacho F
    J Eur Acad Dermatol Venereol; 2001 Jul; 15(4):325-7. PubMed ID: 11730043
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Regression of acanthosis nigricans correlates with disappearance of anti-insulin receptor autoantibodies and achievement of euglycemia in type B insulin resistance syndrome.
    Fareau GG; Maldonado M; Oral E; Balasubramanyam A
    Metabolism; 2007 May; 56(5):670-5. PubMed ID: 17445543
    [TBL] [Abstract][Full Text] [Related]  

  • 51. An overview of dermatological conditions commonly associated with the obese patient.
    Hahler B
    Ostomy Wound Manage; 2006 Jun; 52(6):34-6, 38, 40 passim. PubMed ID: 16799182
    [TBL] [Abstract][Full Text] [Related]  

  • 52. What are the risk factors and settings for non-alcoholic fatty liver disease in Asia-Pacific?
    Fan JG; Saibara T; Chitturi S; Kim BI; Sung JJ; Chutaputti A;
    J Gastroenterol Hepatol; 2007 Jun; 22(6):794-800. PubMed ID: 17498218
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Hepatic dysfunction in Alström disease.
    Connolly MB; Jan JE; Couch RM; Wong LT; Dimmick JE; Rigg JM
    Am J Med Genet; 1991 Sep; 40(4):421-4. PubMed ID: 1746604
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Metabolic syndrome: treatment of hypertensive patients.
    Israili ZH; Lyoussi B; Hernández-Hernández R; Velasco M
    Am J Ther; 2007; 14(4):386-402. PubMed ID: 17667215
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Implications of a clinically ignored site of acanthosis nigricans: the knuckles.
    Gómez-Flores M; González-Saldivar G; Santos-Santos O; Álvarez-Villalobos N; Rodríguez-Gutiérrez R; Tellez-Hinojosa C; González-González J
    Exp Clin Endocrinol Diabetes; 2015 Jan; 123(1):27-33. PubMed ID: 25314648
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Estimation of Metabolic Syndrome in Acanthosis Nigricans - A Hospital Based Cross-Sectional Study.
    Philip NE; Girisha BS; Shetty S; Pinto AM; Noronha TM
    Indian J Dermatol; 2022; 67(1):92. PubMed ID: 35656279
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Acanthosis Nigricans: Pointer of Endocrine Entities.
    Radu AM; Carsote M; Dumitrascu MC; Sandru F
    Diagnostics (Basel); 2022 Oct; 12(10):. PubMed ID: 36292208
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Hyperinsulinemia associated with acanthosis nigricans, finger pebbles, acrochordons, and the sign of Leser-Trélat.
    Saraiya A; Al-Shoha A; Brodell RT
    Endocr Pract; 2013; 19(3):522-5. PubMed ID: 23425641
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clinico-investigative Study of Facial Acanthosis Nigricans.
    Shah VH; Rambhia KD; Mukhi JI; Singh RP; Kaswan P
    Indian Dermatol Online J; 2022; 13(2):221-228. PubMed ID: 35287408
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cardiovascular consequences of obesity.
    Dustan HP
    Chin Med J (Engl); 1992 May; 105(5):360-3. PubMed ID: 1499363
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.